Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes

Seminars in Radiation Oncology

Volumn 22, Issue 1, 2012, Pages 29-39

  Poortmans, Philip ^a   Aznar, Marianne ^b   Bartelink, Harry ^c  

^a Institute Verbeeten   (Netherlands)

^b University of Copenhagen   (Denmark)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL PRACTICE; DISEASE CONTROL; DISEASE COURSE; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RADIATION DOSE; REPRODUCIBILITY; REVIEW; SURVIVAL; TREATMENT PLANNING;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TECHNOLOGY, RADIOLOGIC;

EID: 83455259687     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.09.007     Document Type: Review

References (93)

1. Kong F.M., Klein E.E., Bradley J.D., et al. The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. Int J Radiat Oncol Biol Phys 2002, 54:963-971.
2. Lehman C.D., DeMartini W., Anderson B.O., et al. Indications for breast mri in the patient with newly diagnosed breast cancer. J Natl Compr Cancer Netw 2009, 7:193-201.
3. Straver M.E., Loo C.E., Rutgers E.J., et al. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy. Ann Surg 2010, 251:701-707.
4. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
5. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
6. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
7. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
8. Straver M.E., Meijnen P., van Tienhoven G., et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010, 17:1854-1861.
9. Curran D., Van Dongen J.P., Aaronson N.K., et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC Trial 10801. Eur J Cancer 1998, 34:307-314.
10. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997, 15:963-968.
11. Polgár C., Fodor J., Orosz Z., et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 2002, 178:615-623.
12. van Tienhoven G., van Bree N.A., Mijnheer B.J., et al. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": The Dummy Run. EORTC Radiotherapy Cooperative Group. Radiother Oncol 1991, 22:290-298.
13. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345:1378-1387.
14. Antonini N., Jones H., Horiot J.C., et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC Trial 22881-10882. Radiother Oncol 2007, 82:265-271.
15. Van Werkhoven E., Hart G., Van Tinteren H., et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011, 100:101-107.
16. Collette S., Collette L., Budiharto T., et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC Trial 22881-10882 "boost versus no boost". Eur J Cancer 2008, 44:2587-2599.
17. Vrieling C., Collette L., Fourquet A., et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-concerving therapy in the EORTC "boost vs. no boost" trial. Radiother Oncol 2000, 55:219-232.
18. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2d radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82:254-264.
19. van der Sangen M.J., van de Wiel F.M., Poortmans P.M., et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer?. in Long-Term Results of a Population-Based Cohort of 1,451 Patients Aged
20. Bantema-Joppe E.J., de Munck L., Visser O., et al. Early-stage young breast cancer patients: Impact of local treatment on survival. Int J Radiat Oncol Biol Phys 2011, (in press).
21. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
22. Polgár C., Van Limbergen E., Pötter R., et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence. Radiother Oncol 2010, 94:264-273.
23. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000, 18:2817-2827.
24. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
25. Hurkmans C.W., Borger J.H., Pieters B.R., et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 2001, 50:1366-1372.
26. Pitkänen M.A., Holli K.A., Ojala A.T., et al. Quality assurance in radiotherapy of breast cancer-Variability in planning target volume delineation. Acta Oncol 2001, 40:50-55.
27. Li X.A., Tai A., Arthur D.W., et al. Variability of target and normal structure delineation for breast cancer radiotherapy: An RTOG multi-Institutional and multiobserver Study. Int J Radiat Oncol Biol Phys 2009, 73:944-951.
28. Landis D.M., Luo W., Song J., et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys 2007, 67:1299-1308.
29. Petersen R.P., Truong P.T., Kader H.A., et al. Target volume delineation for partial breast radiotherapy planning: Clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 2007, 69:41-48.
30. Kirby A.M., Coles C.E., Yarnold J.R. Target volume definition for external beam partial breast radiotherapy: Clinical, pathological and technical studies informing current approaches. Radiother Oncol 2010, 94:255-263.
31. van Mourik A.M., Elkhuizen P.H., Minkema D., et al. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol 2010, 94:286-291.
32. Hanbeukers B., Borger J., van den Ende P., et al. Customized computed tomography-based boost volumes in breast-conserving therapy: Use of three-dimensional histologic information for clinical target volume margins. Int J Radiat Oncol Biol Phys 2009, 75:757-763.
33. Al Uwini S., Antonini N., Poortmans P.M., et al. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 2009, 93:87-93.
34. Dijkema I.M., Hofman P., Raaijmakers C.P., et al. Loco-regional conformal radiotherapy of the breast: Delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 2004, 71:287-295.
35. Kiricuta I.C., Götz U., Schwab F., et al. Target volume definition and target conformal irradiation technique for breast cancer patients. Acta Oncol 2000, 39:429-436.
36. Kirova Y.M., Castro Pena P., Dendale R., et al. A Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy. Br J Radiol 2010, 83:683-686.
37. Kirova Y.M., Servois V., Campana F., et al. CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Radiother Oncol 2006, 79:310-315.
38. White J., Tai A., Douglas A., et al. Breast cancer atlas for radiation therapy planning: Consensus definitions, in RTOG Accessed 7 September 2011. http://www.rtog.org/LinkClick.aspx?fileticket=vzJFhPaBipE%3d&tabid=236.
39. Poortmans P., Kouloulias V.E., Venselaar J.L., et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-Medial supraclavicular irradiation in stage I-III breast cancer: The individual case review. Eur J Cancer 2003, 39:2035-2042.
40. Poortmans P.M., Venselaar J.L., Struikmans H., et al. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 2001, 49:1399-1408.
41. Poortmans P., Kouloulias V., van Tienhoven G., et al. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 2006, 182:576-582.
42. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092.
43. Carrasco P., Jornet N., Duch M.A., et al. Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys 2004, 31:2899-2911.
44. Davidson S.E., Popple R.A., Ibbott G.S., et al. Technical note: Heterogeneity dose calculation accuracy in IMRT: Study of five commercial treatment planning systems using an anthropomorphic thorax phantom. Med Phys 2008, 35:5434-5439.
45. Fogliata A., Nicolini G., Vanetti E., et al. The impact of photon dose calculation algorithms on expected dose distributions in lungs under different respiratory phases. Phys Med Biol 2008, 53:2375-2390.
46. Fraass B.A., Kessler M.L., McShan D.L., et al. Optimization and clinical use of multisegment IMRT for high dose conformal therapy. Semin Radiat Oncol 1999, 9:60-77.
47. Vicini F.A., Sharpe M., Kestin L., et al. Optimizing breast cancer treatment efficacy with IMRT. Int J Radiat Oncol Biol Phys 2002, 54:1336-1344.
48. Borghero Y.O., Salehpour M., McNeese M.D., et al. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: A phantom model comparison. Radiother Oncol 2007, 82:324-328.
49. Peulen H., Hanbeukers B., Boersma L., et al. Forward intensity-modulated radiotherapy planning in breast cancer to improve dose homogeneity: Feasibility of class solutions. Int J Radiat Oncol Biol Phys 2011, (in press).
50. Jagsi R., Ben-David M.A., Moran J.M., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:71-78.
51. Fournier-Bidoz N., Kirova Y., Campana F., et al. Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy. J Med Phys 2009, 34:149-152.
52. van der Laan H.P., Dolsma W.V., Schilstra C., et al. Limited benefit of inversely optimised intensity modulation in breast conserving radiotherapy with simultaneously integrated boost. Radiother Oncol 2010, 94:307-312.
53. Moon S.K., Kim Y.S., Kim S.Y., et al. A dosimetric analysis of IMRT and multistatic fields techniques for left breast radiotherapy. Med Dosim 2011, 36:276-283.
54. Dogan N., Cuttino L., Lloyd R., et al. Optimized dose coverage of regional lymph nodes in breast cancer: The role of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68:1238-1250.
55. Krueger E.A., Fraass B.A., McShan D.L., et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003, 15:1023-1037.
56. Korreman S.S., Pedersen A.N., Aarup L.R., et al. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2006, 65:1375-1380.
57. Sixel K.E., Aznar M.C., Ung Y.C. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 2001, 49:199-204.
58. Remouchamps V.M., Vicini F.A., Sharpe M.B., et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2003, 55:392-406.
59. Kantorowitz D.A. The impact of dose-specification policies upon nominal radiation dose received by breast tissue in the conservations treatment of breast cancer. In J Radiat Oncol Biol Phys 2000, 47:841-848.
60. Bel A., Vos P.H., Rodrigus P.T., et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 1996, 35:321-332.
61. de Boer H.C., Heijmen B.J. A protocol for the reduction of systematic patient setup errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys 2001, 50:1350-1365.
62. Topolnjak R., Sonke J.J., Nijkamp J., et al. Breast patient setup error assessment: Comparison of electronic portal image devices and cone-beam computed tomography matching results. Int J Radiat Oncol Biol Phys 2010, 78:1235-1243.
63. Kirby A.M., Evans P.M., Donovan E.M., et al. Prone versus supine positioning for whole and partial-breast radiotherapy: A comparison on non-target tissue dosimetry. Radiother Oncol 2010, 96:178-184.
64. Morrow N.V., Stepaniak C., White J., et al. Intra- and interfractional variations for prone breast irradiation: An indication for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2007, 69:910-917.
65. Korreman S.S., Juhler-Nøttrup T., Fredberg Persson G.F., et al. The role of image guidance in respiratory gated radiotherapy. Acta Oncol 2008, 47:1390-1396.
66. Keall P.J., Mageras G.S., Balter J.M., et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006, 33:3874-3900.
67. Moran J.M., Balter J.M., Ben-David M.A., et al. Short-term displacement and reproducibility of the breast and nodal targets under active breathing control. Int J Radiat Oncol Biol Phys 2007, 68:541-546.
68. Borst G.R., Sonke J.J., den Hollander S., et al. Clinical results of image-guided deep inspiration breath hold breast irradiation. Int J Radiat Oncol Biol Phys 2010, 78:1345-1351.
69. Hasan Y., Kim L., Martinez A., et al. Image guidance in external beam accelerated partial breast irradiation: Comparison of surrogates for the lumpectomy cavity. Int J Radiat Oncol Biol Phys 2008, 70:619-625.
70. Kim L.H., Wong J., Yan D. On-line localization of the lumpectomy cavity using surgical clips. Int J Radiat Oncol Biol Phys 2007, 69:1305-1309.
71. Taylor C.W., Nisbet A., McGale P., et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007, 69:1484-1495.
72. Taylor C.W., Brønnum D., Darby S.C., et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol 2011, 100:176-183.
73. Paszat L.F., Vallis K.A., Benk V.M., et al. A population based case cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 2007, 82:294-300.
74. Borger J.H., Hooning M.J., Boersma L.J., et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: The role of irradiated heart volume. Int J Radiat Oncol Biol Phys 2007, 67:1131-1138.
75. Gagliardi G., Constine L.S., Moiseenko V., et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010, 76(suppl):S77-S85.
76. Schultz Hector S., Trott K.R. Radiation-induced cardiovascular diseases: Is the epidemiologic eveidence compatible with the radiobiologic data. Int J Radiat Oncol Biol Phys 2007, 67:10-18.
77. Aznar M.C., Korreman S.S., Pedersen A.N., et al. Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol 2011, 84:743-746.
78. Jackson A., Marks L.B., Bentzen S.M., et al. The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010, 76(suppl):S155-S160.
79. Demirci S., Nam J., Hubbs J.L., et al. Radiation-induced cardiac toxicity after therapy for breast cancer: Interaction between treatment era and follow-up duration. Int J Radiat Oncol Biol Phys 2009, 73:980-987.
80. Leer J.W., Caspers R.J., van Lonkhuijzen L.R., et al. Selective avoidance of postoperative locoregional radiotherapy in breast cancer seems to be justified. Eur J Surg 1997, 163:815-822.
81. Liengsawangwong R., Yu T.K., Sun T.L., et al. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 2007, 69:711-715.
82. Kirova Y.M., Campana F., Fournier-Bidoz N., et al. Postmastectomy electron beam chest wall irradiation in women with breast cancer: A clinical step toward conformal electron therapy. Int J Radiat Oncol Biol Phys 2007, 69:1139-1144.
83. Feng M., Moran J.M., Koelling T., et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011, 79:10-18.
84. Khatcheressian J.L., Wolff A.C., Smith T.J., et al. Update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006, 24:5091-5097. American Society of Clinical Oncology.
85. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 2005, 75:9-17.
86. Schubert L.K., Gondi V., Sengbusch E., et al. Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol 2011, 100:241-246.
87. Smith W., Menon G., Wolfe N., et al. IMRT for the breast: A comparison of tangential planning techniques. Phys Med Biol 2010, 55:1231-1241.
88. Nicolini G., Vanetti E., Clivio A., et al. Pre-clinical evaluation of respiratory-gated delivery of volumetric modulated arc therapy with RapidArc. Phys Med Biol 2010, 55:N347-N357.
89. Van Mourik A., van Kranen S., den Hollander S., et al. Effects of setup errors and shape changes on breast radiotherapy. Int J Radiat Biol Phys 2011, 79:1557-1564.
90. van Asselen B., Schwarz M., van Vliet-Vroegindeweij C., et al. Intensity-modulated radiotherapy of breast cancer using direct aperture optimization. Radiother Oncol 2006, 79:162-169.
91. Prosnitz R.G., Hubbs J.L., Evans E.S., et al. Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment. Cancer 2007, 110:1840-1850.
92. Evans E.S., Prosnitz R.G., Yu X., et al. Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys 2006, 66:1125-1134.
93. Del Turco, Ponti A., Bick U., et al. Quality indicators in breast cancer care. Eur J Cancer 2010, 46:2344-2356.